Key result
mHealth apps for perimenopausal CVD prevention largely assess individual risk factors over composite scores.
Why the study?
Perimenopause involves cardiometabolic and hormonal changes that increase CVD risk, and the role of mHealth interventions for CVD prevention in this population is not well mapped.
Do mobile health interventions improve primary cardiovascular disease prevention in perimenopausal women?
Do mobile health interventions improve primary cardiovascular disease prevention in perimenopausal women?
There is a lack of menopause-tailored mHealth interventions for primary CVD prevention in perimenopausal women, particularly in low- and middle-income countries.
Answers are grounded in this paper and cite their sources.
Limits mHealth guidance for perimenopausal CVD prevention; leaves open need for composite-risk trials in tailored interventions.
Background/Objectives Perimenopause is characterized by cardiometabolic and hormonal changes that increase cardiovascular disease (CVD) risk. Mobile health (mHealth) technologies may support cardiovascular health. This scoping review mapped the evidence on mHealth interventions for CVD prevention among perimenopausal women. Methods Interventional and observational studies were included. MEDLINE Complete, ScienceDirect, Scopus, and Web of Science were searched for studies published between January 2014 and January 2026, following JBI methodology. Results Twelve studies were included, mostly from high-income countries. Only one intervention was tailored to menopause. Mobile app–based interventions were most common; outcomes were mainly assessed by individual risk factors rather than composite CVD risk scores. Conclusions Menopause-tailored pragmatic studies in LMICs, including Arab countries, are needed.
No takes yet. Share an insight, caveat, or question.
Al-Maharma et al. (2026) conducted a review in Cardiovascular disease prevention in perimenopausal women (n=12). Mobile health (mHealth) interventions was evaluated on Individual risk factors and composite CVD risk scores. A scoping review of 12 studies found that mobile app-based interventions for CVD prevention in perimenopausal women mostly assessed individual risk factors rather than composite CVD risk scores.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: